Wednesday, June 24, 2020

US Group Raises Pricing Recommendation For Gilead's Remdesivir In COVID

Gilead Sciences Inc's antiviral remdesivir could be priced up to $5,080 per course based on benefits shown in COVID-19 patients, a U.S. drug pricing research group suggested on Wednesday, above its...

from NDTV News - World-news https://ift.tt/3hX2lsF
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US Cybersecurity Agency Uses Anthropic AI Model To Audit Government Software

CISA is using Anthropic's Mythos AI to scan government code repositories for security bugs, uncovering many vulnerabilities amid ongoing...